Chronic kidney disease and sudden death: Strategies for prevention

Blood Purification

Volumn 22, Issue 1, 2004, Pages 136-142

  McCullough, Peter A ^a   Sandberg, Keisha R ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Chronic kidney disease; Defibrillation threshold; Implantable cardioverter defibrillator; Mortality; Ventricular arrhythmias

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MAGNESIUM; POTASSIUM;

ACIDOSIS; ASYSTOLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVERSION; CHRONIC KIDNEY DISEASE; DEFIBRILLATION; DISEASE ASSOCIATION; ELECTROLYTE BALANCE; GLOMERULUS FILTRATION; HEART ARRHYTHMIA; HEART BLOCK; HEART DEATH; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; POTASSIUM TRANSPORT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; VALVULAR HEART DISEASE;

ADRENERGIC BETA-ANTAGONISTS; ARRHYTHMIA; CARDIOVASCULAR AGENTS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HEART FUNCTION TESTS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; OUTCOME ASSESSMENT (HEALTH CARE); RISK FACTORS;

EID: 0942268186     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074934     Document Type: Review

References (57)

1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1-12.
2. Brown JH, Hunt LP, Vites NP, Short CD, Gokal R, Mallick NP: Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 1994;8:1136-1142.
3. Asinger RW, Henry TD, Herzog CA, Paulsen PR, Kane RL: Clinical outcomes of PTCA in chronic renal failure: A case-control study for comorbid features and evaluation of dialysis dependence. J Invasive Cardiol 2001;13:21-28.
4. Nakayama Y, Sakata R, Ura M, Miyamoto TA: Coronary artery bypass grafting in dialysis patients. Ann Thorac Surg 1999;68:1257-1261.
5. Samuels LE, Sharma S, Morris RJ, Kuretu ML, Grunewald KE, Strong MD 3rd, Brockman SK: Coronary artery bypass grafting in patients with chronic renal failure. J Card Surg 1996;11:128-133.
6. Tamura K, Tsuji H, Nishiue T, Tokunaga S, Yajima I, Higashi T, Iwasaka T: Determinants of ventricular arrhythmias in hemodialysis patients. Evaluation of the effects of arrhythmogenic substrate and autonomic imbalance. Am J Nephrol 1998;18:280-284.
7. de Lima JJ, Vieira ML, Lopes HF, Gruppi CJ, Medeiros CJ, Ianhez LE, Krieger EM: Blood pressure and the risk of complex arrhythmia in renal insufficiency, hemodialysis and renal transplant patients. Am J Hypertens 1999;12:204-208.
8. Gilman JK, Jalal S, Naccarelli GV: Predicting and preventing sudden death from cardiac causes. Circulation 1994;90:1083-1092.
9. McCullough PA, Soman SS, Shah SS, Smith ST, Marks KR, Yee J, Borzak S: Risks associated with renal dysfunction in coronary care unit patients. J Am Coll Cardiol 2000;36:679-684.
10. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 1996;27:347-354.
11. Kaplinsky E: Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality. Cardiovasc Drugs Ther 1994;8:549-556.
12. Savage T, Giles M, Tomson CV, Raine AE: Gender differences in mediators of left ventricular hypertrophy in dialysis patients. Clin Nephrol 1998;49:107-112.
13. Takeda K, Nakamoto M, Baba M, Tanaka T, Yasunaga C, Nishihara G, Matsuo K, Urabe M: Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients. Clin Nephrol 1998;49:308-312.
14. Gruppo Emodialisi e Patologie Cardiovasculari: Multicentre, cross-sectional study of ventricular arrhythmias in chronically haemodialysed patients. Lancet 1998;ii:305-309.
15. Saragoca MA, Canziani ME, Cassiolato JL, Gil MA, Andrade JL, Draibe SA, Martinez EE: Left ventricular hypertrophy as a risk factor for arrhythmias in hemodialysis patients. J Cardiovasc Pharmacol 1991;17:S136-S138.
16. Parfrey PS, Harnett JD, Griffiths SM, Taylor R, Hand J, King A, Barre PE: The clinical course of left ventricular hypertrophy in dialysis patients. Nephron 1990;55:114-120.
17. Mall G, Huther W, Schneider J, Lundin P, Ritz E: Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant 1990;5:39-44.
18. Lubbecke F, Steudle V, Schutterle G, Wizemann V: Catecholaminergic and muscarinergic receptors in chronic experimental uremia. Clin Physiol Biochem 1989;7:149-160.
19. Dhein S, Rohnert P, Markau S, Kotchi-Kotchi E, Becker K, Poller U, Osten B, Brodde OE: Cardiac beta-adrenoceptors in chronic uremia: Studies in humans and rats. J Am Coll Cardiol 2000;36:608-617.
20. Lubbecke F, Steudle V, Schaper J, Wizemann V: Experimental uremic cardiomyopathy - Fact or fiction? Contrib Nephrol 1986;52:134-145.
21. Lubbecke F: Myocardial alterations in chronic experimental renal failure. Contrib Nephrol 1994;106:7-12.
22. Mann JF, Jakobs KH, Riedel J, Ritz E: Reduced chronotropic responsiveness of the heart in experimental uremia. Am J Physiol 1986;250:H846-H852.
23. McMahon AC, Vescovo G, Dalla Libera L, Wynne DG, Fluck RJ, Harding SE, Raine AE: Contractile dysfunction of isolated ventricular myocytes in experimental uraemia. Exp Nephrol 1996;4:144-150.
24. Kreusser W, Rambausek M, Klooker P, Bruckner U, Ritz E: Hemodynamics and cardiac metabolism in experimental uremia. Contrib Nephrol 1984;41:262-265.
25. Rambausek M, Mann JF, Mall G, Kreusser W, Ritz E: Cardiac findings in experimental uremia. Contrib Nephrol 1986;52:125-133.
26. Weisensee D, Schnaars Y, Schoeppe W, Bereiter-Hahn J, Low-Friedrich I: Potential uremic toxins modulate energy metabolism of cardiac myocytes in vitro. Exp Nephrol 1997;5:194-200.
27. Weisensee D, Low-Friedrich I, Riehle M, Bereiter-Hahn J, Schoeppe W: In vitro approach to 'uremic cardiomyopathy'. Nephron 1993;65:392-400.
28. Tun A, Khan IA, Wattanasauwan N, Win MT, Hussain A, Hla TA, Cherukuri VL, Vasavada BC, Sacchi TJ: Increased regional and trans-myocardial dispersion of ventricular repolarization in end-stage renal disease. Can J Cardiol 1999;15:53-56.
29. Donohoe P, McMahon AC, Walgama OV, Bertaso F, Dockrell ME, Cramp HA, Mullen AM, Shattock MJ, Hendry BM, James AF: L-type calcium current of isolated rat cardiac myocytes in experimental uraemia. Nephrol Dial Transplant 2000;15:791-798.
30. Druml W, Kelly RA, England BK, O'Hara DS, Mitch WE: Effects of acute and chronic uremia on active cation transport in rat myocardium. Kidney Int 1990;38:1061-1067.
31. Rambausek M, Amann K, Mall G, Ritz E: Structural causes of cardiac dysfunction in uremia. Ren Fail 1993;15:421-428.
32. Rambausek M, Kollmar S, Klug D, Mehls O, Ritz E: Regulation of myocardial isomyosin V1 in uraemic rats. Eur J Clin Invest 1991;21:64-71.
33. Roithinger FX, Punzengruber C, Rossoll M, Pachinger O, Kramar R, Prischl FC: Ventricular late potentials in haemodialysis patients and the risk of sudden death. Nephrol Dial Transplant Proc 1992;7:1013-1018.
34. Amann K, Breitbach M, Ritz E, Mall G: Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998;9:1018-1022.
35. Amann K, Munter K, Wessels S, Wagner J, Balajew V, Hergenroder S, Mall G, Ritz E: Endothelin A receptor blockade prevents capillary/myocyte mismatch in the heart of uremic animals. J Am Soc Nephrol 2000;11:1702-1711.
36. Chhabra SC, Sandha GS, Wander GS: Incidence of cardiac arrhythmias in chronic renal failure, especially during hemodialysis. Nephron 1991;57:500-501.
37. Kinoshita O, Kamakura S, Kimura G, Omae T: Increased ventricular vulnerability during hemodialysis. Lancet 1991;338:1333-1334.
38. Cupisti A, Galetta F, Caprioli R, Morelli E, Tintori GC, Franzoni F, Lippi A, Meola M, Rindi P, Barsotti G: Potassium removal increases the Q-Tc interval dispersion during hemodialysis. Nephron 1999;82:122-126.
39. Cupisti A, Galetta F, Morelli E, Tintori G, Sibilia G, Meola M, Barsotti G: Effect of hemodialysis on the dispersion of the QTc interval. Nephron 1998;78:429-432.
40. Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, McCullough PA: Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001;37:1191-2000.
41. Shilpak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002;137:555-562.
42. Wright RS, Jaffe AS, Miller WL, Murphy JG, Albright R, Dvorak D, Williams BA, Kopecky SL, Reeder GS: Renal dysfunction and acute myocardial infarction: A gradient of risk (abstract). Circulation 2001;104(suppl 2).
43. Askari AT, Aviles RJ, Gurm HS, Gang J, Barnathan ES, Cooper JC, Topol E: Baseline serum creatinine predicts outcome in patients presenting with acute coronary syndromes: Insight from GUSTO IV (abstract). Circulation 2001;104(suppl 2).
44. Szczech LA, Best PJ, Crowley E, Brooks MM, Berger PB, Bittner V, Gersh BJ, Jones R, Califf RM, Ting HH, Whitlow PJ, Detre KM, Holmes D, for the BARI Investigators: Outcomes of patients with chronic renal insufficiency in the Bypass Angioplasty Revascularization Investigation. Circulation 2002;105:2253-2258.
45. Soman SS, Sandberg KR, Borzak S, Hudson MP, Yee J, McCullough PA: The independent association of renal dysfunction and arrhythmias in critically ill patients. Chest 2002;122:669-677.
46. National Kidney Foundation: Clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;2(suppl 1):S46-S47.
47. McCullough PA, Sandberg KR, Yee J, Hudson MP: Mortality benefit of angiotensin-converting enzyme inhibitors after cardiac events in patients with end-stage renal disease. J Renin Angiotensin Aldosterone Syst 2002;3:188-191.
48. McCullough PA, Sandberg KR, Borzak S, Hudson MP, Garg M, Manley HJ: Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J 2002;144:226-232.
49. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M, for the Multicenter Automatic Defibrillation Implantation Trial Investigators: Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Eng J Med 1996:335:1933-1940.
50. The Antiarrhythmics versus Implantable Defibrillators Investigators: A comparison of anti-arrhythmic-drug therapy with implantable defibrillator in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
51. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
52. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992;327:1912-1918.
53. Wase A, Basit A, Nazir R: Does chronic renal insufficiency raise defibrillation threshold? Pacing Clin Electrophysiol 2002;25(4, part II):594.
54. Epstein AE, Ellenbogen KA, Kirk KA, Kay GN, Dailey SM, Plumb VJ, for the High Defibrillation Threshold Investigators: Clinical characteristics and outcome of patients with high defibrillation thresholds - A Multicenter Study. Circulation 1992;86:1206-1216.
55. McCullough PA: Why is chronic kidney disease the 'spoiler' for cardiovascular outcomes? J Am Coll Cardiol 2003;41:725-728.
56. Collins AJ, Li S, Ma JZ, Herzog CA: Cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis 2001;38(suppl 1):S26-S29.
57. Herzog CA: Cardiac arrest in dialysis patients: Approaches to alter an abysmal outcome. Kidney Int 2003;84(suppl):S197-S200.